| __timestamp | BioCryst Pharmaceuticals, Inc. | Blueprint Medicines Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 51796000 | 31844000 |
| Thursday, January 1, 2015 | 72758000 | 48588000 |
| Friday, January 1, 2016 | 61008000 | 81131000 |
| Sunday, January 1, 2017 | 66962000 | 144687000 |
| Monday, January 1, 2018 | 84888000 | 243621000 |
| Tuesday, January 1, 2019 | 107068000 | 331450000 |
| Wednesday, January 1, 2020 | 122964000 | 326860000 |
| Friday, January 1, 2021 | 208808000 | 601033000 |
| Saturday, January 1, 2022 | 253297000 | 477419000 |
| Sunday, January 1, 2023 | 216566000 | 427720000 |
| Monday, January 1, 2024 | 341433000 |
Unleashing the power of data
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Blueprint Medicines Corporation and BioCryst Pharmaceuticals, Inc. have been at the forefront of this race. From 2014 to 2023, Blueprint Medicines has consistently outpaced BioCryst in R&D investment, with a peak in 2021 where it spent nearly 60% more than BioCryst. This trend highlights Blueprint's aggressive push towards groundbreaking therapies. However, BioCryst has shown a steady increase in its R&D budget, doubling its spending from 2014 to 2023. This strategic allocation of resources underscores the company's dedication to advancing its pipeline. As these two biotech giants continue to innovate, their R&D spending patterns offer a glimpse into their future trajectories and potential breakthroughs.
Eli Lilly and Company vs Blueprint Medicines Corporation: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Bristol-Myers Squibb Company vs BioCryst Pharmaceuticals, Inc.
Intra-Cellular Therapies, Inc. vs Blueprint Medicines Corporation: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Bio-Techne Corporation vs BioCryst Pharmaceuticals, Inc.
Analyzing R&D Budgets: BioMarin Pharmaceutical Inc. vs BioCryst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and BioCryst Pharmaceuticals, Inc.
Blueprint Medicines Corporation or CymaBay Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Opthea Limited and BioCryst Pharmaceuticals, Inc.
Research and Development Investment: Viking Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.
R&D Spending Showdown: Amicus Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.
Analyzing R&D Budgets: Mesoblast Limited vs BioCryst Pharmaceuticals, Inc.
R&D Insights: How BioCryst Pharmaceuticals, Inc. and Evotec SE Allocate Funds